FIVE vs VRTX · P/E 28, rev $1.39B vs P/E 30, rev $12.00B
Five Below Inc (FIVE) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Five Below Inc (FIVE) is a specialty retail company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
FIVE currently screens at market cap $7.30B and trailing P/E 27.7. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the FIVE and VRTX stock pages for the full models.
Not investment advice.